From Biology to Therapy: The CLL Success Story
Chemoimmunotherapy has been the standard of care for patients with chronic lymphocytic leukemia (CLL) over the last decade. Advances in monoclonal antibody technology have resulted in the development of newer generations of anti-CD20 antibodies with improved therapeutic effectiveness. In parallel, o...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Text |
| Language: | English |
| Published: |
Wolters Kluwer Health
2019
|
| Subjects: | |
| Online Access: | https://pmc.ncbi.nlm.nih.gov/articles/PMC6746030/ https://pubmed.ncbi.nlm.nih.gov/31723816 http://dx.doi.org/10.1097/HS9.0000000000000175 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|